Professor
Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Westerville, Ohio, United States
Dr. Spero Cataland is a Professor of Internal Medicine in the Division of Hematology at the Wexner Medical Center at The Ohio State University. He is also the Director of the Benign Hematology Program at Ohio State University. Dr. Cataland received his medical degree from Ohio State University College of Medicine and completed his residency at Ohio State University Hospital, after which he went on to complete fellowship training in hematology/oncology at the University of Chicago Medical Center. After completing his training in hematology he returned to Ohio State University where he presently remains on the faculty.
Dr. Cataland's clinical and research interests include thrombotic thrombocytopenic purpura (TTP) and atypical hemolytic uremic syndrome (aHUS) with an emphasis on immune-mediated TTP (iTTP). Dr. Cataland directs the Biomarker Reference Laboratory at Ohio State University that performs correlative laboratory studies for ongoing research. Dr. Cataland has a long standing interest in the development of long-term complications in patients with a prior history of TTP and the mechanisms for their development. Dr. Cataland has also worked to establish the United States Thrombotic Microangiopathy Clinical Consortium, an organization of over 15 academic medical centers that was organized to conduct collaborative research in TTP and aHUS.